Global Peptide Therapeutics Market : Market Insights, Competition and Forecast (2021-2026)
The companies analysed in the report include Novartis, Sanofi, Pfizer, GlaxoSmithKline, Eli Lily and Company, AstraZeneca Plc., Novo Nordisk, Amgen Inc., Takeda Pharmaceutical Company Limited, Bristol-Mayer Squibb
By: Azoth Analytics
New drug discovery and product launch in chronic metabolic disorders expected to provide potential opportunities to Peptide Therapeutics Market, further supported by factors such as surging prevalence of cancer, rising healthcare expenditure, growing incidence of metabolic disorders, increasing geriatric population and accelerating number of approved peptide-based therapeutic drugs.
The success of peptide therapeutics, so far, can be attributed to their clinical benefits, which include high target specificity, low toxicity and favourable safety profiles. Furthermore, with enhanced technologies, the prospects of the peptide drugs are getting influential day by day and new peptides are being discovered to be developed as peptide drug. Peptide therapeutics is completely different from the traditional methods and may open a new window for finding completely new peptide drugs.
Scope of the Report
For more Information:
(Business Development Manager)
Address: CS - 55, Third Floor, Ansal Plaza,
Tel: +91-120- 4298235
Mail ID - email@example.com